Eris Lifesciences Limited

NSE:ERIS.NS

1397.05 (INR) • At close September 18, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

2024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q22016 Q1
Assets:
Current Assets:
Cash & Cash Equivalents -14,006.3214,006.3-1,906.241,727.14-892.43560.22-709.59677.11-2,123.17507.94-1,487.26426.71-1,365.06368.7-2,052.6512.14-1,537.18672.11-2,481.62122.82-3,353.9675-816.14143.41-1,127.01106.08-2,665.1257.29-2,609.0424.2197.41-1,371.39
Short Term Investments 28,012.640.023,812.48195.21,784.86332.211,419.1832.484,246.341,264.472,974.521,060.552,730.12153.994,105.21,540.463,074.36747.814,963.242,358.86,707.923,149.421,632.28672.732,254.02937.895,330.242,607.835,218.082,584.832,522.82,742.78
Cash and Short Term Investments 14,006.3214,006.321,906.241,922.34892.43892.43709.59709.592,123.171,772.411,487.261,487.261,365.06522.692,052.62,052.61,537.181,419.922,481.622,481.623,353.963,224.42816.14816.141,127.011,043.972,665.122,665.122,609.042,609.042,620.211,371.39
Net Receivables 04,275.8303,549.0202,966.9502,95701,61001,669.602,280.6101,954.2301,568.8401,408.2801,760.3701,175.090761.30934.410603.99561.390
Inventory 01,890.3201,390.8901,314.3501,085.1901,179.1101,031.420944.660902.670694.750720.910826.530582.640654.480357.550558.2507.460
Other Current Assets 02,848.2602,749.2602,473.4901,354.9401,060.8501,035.650922.501,087.7602,681.50703.7406.470702.540527.320319.3073.54191.860
Total Current Assets 14,006.3223,020.731,906.249,611.51892.437,647.22709.596,154.362,123.176,273.31,487.265,223.931,365.064,670.462,052.65,997.261,537.184,796.172,481.625,314.553,353.965,817.79816.143,276.411,127.012,987.072,665.124,276.382,609.043,844.773,880.921,371.39
Non-Current Assets:
Property, Plant & Equipment, Net 05,236.5304,224.6303,773.7902,994.1501,918.5701,404.30778.780778.680872.430951.040560.710590.030526.120550.660553.86610.430
Goodwill 08,612.1303,318.4903,318.4903,378.620934.740934.740934.740934.740934.740935.870935.870934.7401,869.480371.590792.6100
Intangible Assets 029,623.25018,236.07018,805.96012,874.3706,595.9806,691.7406,840.7606,907.7906,984.6906,084.3206,136.0806,193.9806,250.0701,462.350363.34377.370
Goodwill and Intangible Assets 038,235.38021,554.56022,124.45016,252.9907,530.7207,626.4807,775.507,842.5307,919.4307,020.1907,071.9507,128.7208,119.5501,833.9401,155.95377.370
Long Term Investments 0259.140-52.34068.77042.2304,208.4403,851.7702,282.460-1,409.250-715.770-1,881.50-2,740.302,207.3901,797.380-1,042.270-2,483.86100.970
Tax Assets 03,069.4102,951.0302,739.4502,694.8602,431.3402,271.7202,006.3201,952.1301,709.1101,591.8801,447.9401,253.9201,005.670789.76095.1500
Other Non-Current Assets -14,006.32667.18-1,906.24462.49-892.43319.6-709.59552.78-2,123.17359.02-1,487.26139.24-1,365.06834.28-2,052.61,685.58-1,537.18941.68-2,481.622,508.73-3,353.963,378.53-816.14752.11-1,127.01165.06-2,665.122,676.05-2,609.043,244.1521.2-1,371.39
Total Non-Current Assets -14,006.3247,467.64-1,906.2429,140.37-892.4329,026.06-709.5922,537.01-2,123.1716,448.09-1,487.2615,293.51-1,365.0613,677.34-2,052.610,849.67-1,537.1810,726.88-2,481.6210,190.34-3,353.969,718.83-816.1411,932.17-1,127.0111,613.78-2,665.124,808.14-2,609.042,565.21,609.97-1,371.39
Total Assets 070,488.37038,751.88036,673.28028,691.37022,721.39020,517.44018,347.8016,846.93015,523.05015,504.89015,536.62015,208.58014,600.8509,084.5206,409.975,490.890
Liabilities & Equity:
Current Liabilities:
Account Payables 02,683.4801,505.2501,247.6901,165.701,177.7401,167.8201,026.160994.2901,000.510729.480841.250893.750907.740607.120385.17608.350
Short Term Debt 020,897.4301,970.3101,932.901,391.27040.13043.69023.3037.08059.99086.1601,761.301,023.2601,026.0400072.6544.330
Tax Payables 0395.90137.960390141.24069.970192.83077.510126.43069.98023.28018.11018.82025.57083.520000
Deferred Revenue 0395.901,274.4401,034.5208060626.220561.4077.510493.720424.320397.510271.410-1,023.260225.57000241.7600
Other Current Liabilities 01,343.960221.380217.220235.510152.370213.630542.340213.060162.0801750181.4101,358.7095.250387.28058.61312.80
Total Current Liabilities 025,320.7704,971.3804,432.3303,598.4801,996.4601,986.5401,669.3101,738.1501,646.901,388.1503,055.3702,252.4502,254.60994.40758.19965.480
Non-Current Liabilities:
Long Term Debt 06,545.0706,324.7306,834.2101,227.550803.940399.73044.47051.13061.44083.1102.9301,747.8402,741.9504.2404.9400
Deferred Revenue Non-Current 0370.190536.1087.390550.29056.880372.61061.110350.98085.450252.62066.630228.250209.720190.43010.7800
Deferred Tax Liabilities Non-Current 05,428.1802,533.0402,576.3802,618.160460.940478.150495.380500.740506.150511.550516.950520.580522.70343.040211.5300
Other Non-Current Liabilities 0603.850110.90536.20124.960321.14024.650313.3026.410259.77030.640206.47012.36012.16011.48025.2900
Total Non-Current Liabilities 012,947.2909,504.77010,034.1804,520.9601,642.901,275.140914.260929.260912.810877.920792.9802,509.0303,486.530549.190252.5400
Total Liabilities 038,268.06014,476.15014,466.5108,119.4403,639.3603,261.6802,583.5702,667.4102,559.7102,266.0703,848.3504,761.4805,741.1301,543.5901,010.73965.480
Equity:
Preferred Stock 0000021,930.1200018,978.590000000000000000000000
Common Stock 0136.030136.020135.990135.990135.930135.910135.780135.780135.780137.520137.50137.520137.50137.50137.5137.50
Retained Earnings 025,492.5700021,559.300018,736.5300015,503.1300012,797.2800011,335.22010,057.9908,468.570005,254.744,155.240
Accumulated Other Comprehensive Income/Loss 25,861.1951,450.3224,115.6823,979.6621,959.8829.7620,269.3720,133.3819,083.11104.5217,255.7417,119.8315,764.21135.7814,179.514,043.7212,963.34-711.3313,238.8213,101.311,505.18-543.9910,195.5108,613.0707,306.797,169.295,399.24-619.9602,992.44
Other Total Stockholders Equity 6,359.12-51,217.73160.050246.89-21,695.29302.560-1.08-18,872.460.0200.02-10.480.0200741.6100183.11576.43251.590246.657234.1400626.96-4,292.7432.01
Total Shareholders Equity 32,220.3125,861.1924,275.7324,115.6822,206.7721,959.8820,571.9320,269.3719,082.0319,083.1117,255.7617,255.7415,764.2315,764.2114,179.5214,179.512,963.3412,963.3413,238.8213,238.8211,688.2911,505.1610,447.110,195.518,859.728,613.077,540.937,306.795,399.245,399.244,292.743,024.45
Total Equity 32,220.3132,220.3124,275.7324,275.7322,206.7722,206.7720,571.9320,571.9319,082.0319,082.0317,255.7617,255.7615,764.2315,764.2314,179.5214,179.5212,963.3412,963.3413,238.8213,238.8211,688.2911,688.2710,447.110,447.18,859.728,859.727,540.937,540.935,399.245,637.174,292.743,024.45
Total Liabilities & Shareholders Equity 32,220.3170,488.3724,275.7338,751.8822,206.7736,673.2820,571.9328,691.3719,082.0322,721.3917,255.7620,517.4415,764.2318,347.814,179.5216,846.9312,963.3415,523.0513,238.8215,504.8911,688.2915,536.6210,447.115,208.588,859.7214,600.857,540.939,084.525,399.246,409.975,258.223,024.45